nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—Lamotrigine—epilepsy syndrome	0.774	1	CrCtD
Triamterene—CYP1A2—Carbamazepine—epilepsy syndrome	0.015	0.203	CbGbCtD
Triamterene—CYP1A2—Primidone—epilepsy syndrome	0.014	0.19	CbGbCtD
Triamterene—CYP1A2—Propofol—epilepsy syndrome	0.0125	0.17	CbGbCtD
Triamterene—CYP1A2—Phenobarbital—epilepsy syndrome	0.012	0.162	CbGbCtD
Triamterene—CYP1A2—Diazepam—epilepsy syndrome	0.0114	0.154	CbGbCtD
Triamterene—CYP1A2—Valproic Acid—epilepsy syndrome	0.00895	0.121	CbGbCtD
Triamterene—SCNN1D—forebrain—epilepsy syndrome	0.00158	0.122	CbGeAlD
Triamterene—SCNN1D—telencephalon—epilepsy syndrome	0.00145	0.112	CbGeAlD
Triamterene—SCNN1A—telencephalon—epilepsy syndrome	0.00113	0.0874	CbGeAlD
Triamterene—Lamotrigine—SCN8A—epilepsy syndrome	0.000936	0.225	CrCbGaD
Triamterene—SCNN1D—head—epilepsy syndrome	0.000903	0.0697	CbGeAlD
Triamterene—SCNN1D—nervous system—epilepsy syndrome	0.000856	0.0661	CbGeAlD
Triamterene—SCNN1D—central nervous system—epilepsy syndrome	0.000824	0.0636	CbGeAlD
Triamterene—SCNN1D—cerebellum—epilepsy syndrome	0.000805	0.0622	CbGeAlD
Triamterene—SCNN1G—cerebellum—epilepsy syndrome	0.000805	0.0622	CbGeAlD
Triamterene—SCNN1B—head—epilepsy syndrome	0.000763	0.0589	CbGeAlD
Triamterene—Lamotrigine—SCN9A—epilepsy syndrome	0.000757	0.182	CrCbGaD
Triamterene—Lamotrigine—SCN3A—epilepsy syndrome	0.000724	0.174	CrCbGaD
Triamterene—SCNN1B—nervous system—epilepsy syndrome	0.000723	0.0558	CbGeAlD
Triamterene—SCNN1A—head—epilepsy syndrome	0.000705	0.0544	CbGeAlD
Triamterene—SCNN1B—central nervous system—epilepsy syndrome	0.000696	0.0537	CbGeAlD
Triamterene—Lamotrigine—SCN4A—epilepsy syndrome	0.000695	0.167	CrCbGaD
Triamterene—SCNN1D—brain—epilepsy syndrome	0.000654	0.0505	CbGeAlD
Triamterene—SCNN1B—brain—epilepsy syndrome	0.000553	0.0427	CbGeAlD
Triamterene—SCNN1A—brain—epilepsy syndrome	0.000511	0.0394	CbGeAlD
Triamterene—Lamotrigine—SCN1A—epilepsy syndrome	0.000508	0.122	CrCbGaD
Triamterene—Lamotrigine—SCN2A—epilepsy syndrome	0.000448	0.108	CrCbGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.00023	0.00374	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.00023	0.00374	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.00023	0.00374	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000218	0.00355	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000208	0.00338	CbGpPWpGaD
Triamterene—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C19—epilepsy syndrome	0.000189	0.00306	CbGpPWpGaD
Triamterene—Dermatitis—Trimethadione—epilepsy syndrome	0.000189	0.00254	CcSEcCtD
Triamterene—Headache—Trimethadione—epilepsy syndrome	0.000187	0.00253	CcSEcCtD
Triamterene—Photosensitivity reaction—Valproic Acid—epilepsy syndrome	0.000187	0.00253	CcSEcCtD
Triamterene—Dry mouth—Fosphenytoin—epilepsy syndrome	0.000187	0.00252	CcSEcCtD
Triamterene—Asthenia—Rufinamide—epilepsy syndrome	0.000187	0.00252	CcSEcCtD
Triamterene—Thrombocytopenia—Levetiracetam—epilepsy syndrome	0.000186	0.00251	CcSEcCtD
Triamterene—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000183	0.00247	CcSEcCtD
Triamterene—Fatigue—Acetazolamide—epilepsy syndrome	0.000182	0.00246	CcSEcCtD
Triamterene—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00018	0.00243	CcSEcCtD
Triamterene—Thrombocytopenia—Fosphenytoin—epilepsy syndrome	0.000179	0.00242	CcSEcCtD
Triamterene—Dry mouth—Diazepam—epilepsy syndrome	0.000179	0.00242	CcSEcCtD
Triamterene—Diarrhoea—Rufinamide—epilepsy syndrome	0.000178	0.0024	CcSEcCtD
Triamterene—Nausea—Trimethadione—epilepsy syndrome	0.000178	0.0024	CcSEcCtD
Triamterene—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000176	0.00237	CcSEcCtD
Triamterene—Asthenia—Lacosamide—epilepsy syndrome	0.000175	0.00236	CcSEcCtD
Triamterene—Dizziness—Phenobarbital—epilepsy syndrome	0.000175	0.00236	CcSEcCtD
Triamterene—Dry mouth—Felbamate—epilepsy syndrome	0.000173	0.00234	CcSEcCtD
Triamterene—Dizziness—Rufinamide—epilepsy syndrome	0.000172	0.00232	CcSEcCtD
Triamterene—Thrombocytopenia—Diazepam—epilepsy syndrome	0.000172	0.00232	CcSEcCtD
Triamterene—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C19—epilepsy syndrome	0.000172	0.00279	CbGpPWpGaD
Triamterene—Asthenia—Clobazam—epilepsy syndrome	0.00017	0.0023	CcSEcCtD
Triamterene—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00017	0.00229	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.00017	0.00276	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.00017	0.00276	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.00017	0.00276	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.00017	0.00276	CbGpPWpGaD
Triamterene—Dry mouth—Zonisamide—epilepsy syndrome	0.00017	0.00229	CcSEcCtD
Triamterene—Photosensitivity reaction—Pregabalin—epilepsy syndrome	0.000169	0.00229	CcSEcCtD
Triamterene—Fatigue—Propofol—epilepsy syndrome	0.000169	0.00228	CcSEcCtD
Triamterene—Vomiting—Phenobarbital—epilepsy syndrome	0.000169	0.00227	CcSEcCtD
Triamterene—Diarrhoea—Lacosamide—epilepsy syndrome	0.000167	0.00226	CcSEcCtD
Triamterene—Rash—Phenobarbital—epilepsy syndrome	0.000167	0.00225	CcSEcCtD
Triamterene—Dermatitis—Phenobarbital—epilepsy syndrome	0.000167	0.00225	CcSEcCtD
Triamterene—Thrombocytopenia—Felbamate—epilepsy syndrome	0.000166	0.00225	CcSEcCtD
Triamterene—Headache—Phenobarbital—epilepsy syndrome	0.000166	0.00224	CcSEcCtD
Triamterene—Fatigue—Midazolam—epilepsy syndrome	0.000166	0.00223	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000165	0.00269	CbGpPWpGaD
Triamterene—Vomiting—Rufinamide—epilepsy syndrome	0.000165	0.00223	CcSEcCtD
Triamterene—Rash—Rufinamide—epilepsy syndrome	0.000164	0.00221	CcSEcCtD
Triamterene—Dermatitis—Rufinamide—epilepsy syndrome	0.000164	0.00221	CcSEcCtD
Triamterene—Dry mouth—Clonazepam—epilepsy syndrome	0.000164	0.00221	CcSEcCtD
Triamterene—Fatigue—Levetiracetam—epilepsy syndrome	0.000163	0.00221	CcSEcCtD
Triamterene—Headache—Rufinamide—epilepsy syndrome	0.000163	0.0022	CcSEcCtD
Triamterene—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000163	0.0022	CcSEcCtD
Triamterene—Dry mouth—Phenytoin—epilepsy syndrome	0.000162	0.00219	CcSEcCtD
Triamterene—Diarrhoea—Clobazam—epilepsy syndrome	0.000162	0.00219	CcSEcCtD
Triamterene—Dry mouth—Oxcarbazepine—epilepsy syndrome	0.000162	0.00218	CcSEcCtD
Triamterene—Dizziness—Lacosamide—epilepsy syndrome	0.000162	0.00218	CcSEcCtD
Triamterene—Jaundice—Pregabalin—epilepsy syndrome	0.000161	0.00218	CcSEcCtD
Triamterene—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00016	0.00216	CcSEcCtD
Triamterene—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000159	0.00215	CcSEcCtD
Triamterene—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000158	0.00214	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000158	0.00256	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000158	0.00256	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000158	0.00256	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000158	0.00256	CbGpPWpGaD
Triamterene—Nausea—Phenobarbital—epilepsy syndrome	0.000157	0.00212	CcSEcCtD
Triamterene—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000157	0.00212	CcSEcCtD
Triamterene—Dizziness—Clobazam—epilepsy syndrome	0.000157	0.00212	CcSEcCtD
Triamterene—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000156	0.0021	CcSEcCtD
Triamterene—Photosensitivity reaction—Gabapentin—epilepsy syndrome	0.000155	0.0021	CcSEcCtD
Triamterene—Vomiting—Lacosamide—epilepsy syndrome	0.000155	0.0021	CcSEcCtD
Triamterene—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000155	0.00209	CcSEcCtD
Triamterene—Dry mouth—Carbamazepine—epilepsy syndrome	0.000155	0.00209	CcSEcCtD
Triamterene—Nausea—Rufinamide—epilepsy syndrome	0.000155	0.00209	CcSEcCtD
Triamterene—Rash—Lacosamide—epilepsy syndrome	0.000154	0.00208	CcSEcCtD
Triamterene—Dermatitis—Lacosamide—epilepsy syndrome	0.000154	0.00208	CcSEcCtD
Triamterene—Fatigue—Vigabatrin—epilepsy syndrome	0.000154	0.00208	CcSEcCtD
Triamterene—Headache—Lacosamide—epilepsy syndrome	0.000153	0.00206	CcSEcCtD
Triamterene—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000152	0.00205	CcSEcCtD
Triamterene—Asthenia—Acetazolamide—epilepsy syndrome	0.000152	0.00205	CcSEcCtD
Triamterene—Fatigue—Diazepam—epilepsy syndrome	0.000151	0.00204	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000151	0.00246	CbGpPWpGaD
Triamterene—Hypokalaemia—Topiramate—epilepsy syndrome	0.000151	0.00203	CcSEcCtD
Triamterene—Vomiting—Clobazam—epilepsy syndrome	0.000151	0.00203	CcSEcCtD
Triamterene—Dry mouth—Lamotrigine—epilepsy syndrome	0.00015	0.00202	CcSEcCtD
Triamterene—Rash—Clobazam—epilepsy syndrome	0.000149	0.00202	CcSEcCtD
Triamterene—Dermatitis—Clobazam—epilepsy syndrome	0.000149	0.00202	CcSEcCtD
Triamterene—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000149	0.00201	CcSEcCtD
Triamterene—Headache—Clobazam—epilepsy syndrome	0.000149	0.002	CcSEcCtD
Triamterene—Jaundice—Gabapentin—epilepsy syndrome	0.000148	0.002	CcSEcCtD
Triamterene—Fatigue—Felbamate—epilepsy syndrome	0.000147	0.00198	CcSEcCtD
Triamterene—Nausea—Lacosamide—epilepsy syndrome	0.000145	0.00196	CcSEcCtD
Triamterene—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000145	0.00195	CcSEcCtD
Triamterene—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000144	0.00194	CcSEcCtD
Triamterene—Fatigue—Zonisamide—epilepsy syndrome	0.000143	0.00194	CcSEcCtD
Triamterene—Hypersensitivity—Midazolam—epilepsy syndrome	0.000141	0.00191	CcSEcCtD
Triamterene—CYP1A2—Tryptophan metabolism—WARS—epilepsy syndrome	0.000141	0.00229	CbGpPWpGaD
Triamterene—Nausea—Clobazam—epilepsy syndrome	0.000141	0.0019	CcSEcCtD
Triamterene—Asthenia—Propofol—epilepsy syndrome	0.000141	0.0019	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000141	0.00229	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000141	0.00229	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000141	0.00229	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000141	0.00229	CbGpPWpGaD
Triamterene—Dizziness—Acetazolamide—epilepsy syndrome	0.00014	0.00189	CcSEcCtD
Triamterene—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00014	0.00189	CcSEcCtD
Triamterene—Fatigue—Clonazepam—epilepsy syndrome	0.000138	0.00187	CcSEcCtD
Triamterene—Asthenia—Midazolam—epilepsy syndrome	0.000138	0.00186	CcSEcCtD
Triamterene—Fatigue—Phenytoin—epilepsy syndrome	0.000137	0.00185	CcSEcCtD
Triamterene—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000137	0.00184	CcSEcCtD
Triamterene—Asthenia—Levetiracetam—epilepsy syndrome	0.000136	0.00184	CcSEcCtD
Triamterene—Vomiting—Acetazolamide—epilepsy syndrome	0.000134	0.00181	CcSEcCtD
Triamterene—Diarrhoea—Propofol—epilepsy syndrome	0.000134	0.00181	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000134	0.00218	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000134	0.00218	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000134	0.00218	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000134	0.00218	CbGpPWpGaD
Triamterene—Headache—Acetazolamide—epilepsy syndrome	0.000132	0.00179	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000132	0.00215	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000132	0.00215	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000132	0.00215	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000132	0.00215	CbGpPWpGaD
Triamterene—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000131	0.00177	CcSEcCtD
Triamterene—Asthenia—Fosphenytoin—epilepsy syndrome	0.000131	0.00177	CcSEcCtD
Triamterene—Fatigue—Carbamazepine—epilepsy syndrome	0.000131	0.00177	CcSEcCtD
Triamterene—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000131	0.00176	CcSEcCtD
Triamterene—Dizziness—Propofol—epilepsy syndrome	0.00013	0.00175	CcSEcCtD
Triamterene—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00013	0.00175	CcSEcCtD
Triamterene—Hypersensitivity—Diazepam—epilepsy syndrome	0.000129	0.00175	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000129	0.00209	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000129	0.00209	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000129	0.00209	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000129	0.00209	CbGpPWpGaD
Triamterene—Asthenia—Vigabatrin—epilepsy syndrome	0.000128	0.00173	CcSEcCtD
Triamterene—Dizziness—Midazolam—epilepsy syndrome	0.000127	0.00171	CcSEcCtD
Triamterene—Fatigue—Lamotrigine—epilepsy syndrome	0.000127	0.00171	CcSEcCtD
Triamterene—Asthenia—Diazepam—epilepsy syndrome	0.000126	0.0017	CcSEcCtD
Triamterene—Nausea—Acetazolamide—epilepsy syndrome	0.000126	0.00169	CcSEcCtD
Triamterene—Dizziness—Levetiracetam—epilepsy syndrome	0.000125	0.00169	CcSEcCtD
Triamterene—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000125	0.00169	CcSEcCtD
Triamterene—Vomiting—Propofol—epilepsy syndrome	0.000125	0.00168	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000124	0.00201	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000124	0.00201	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000124	0.00201	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000124	0.00201	CbGpPWpGaD
Triamterene—Rash—Propofol—epilepsy syndrome	0.000124	0.00167	CcSEcCtD
Triamterene—Dermatitis—Propofol—epilepsy syndrome	0.000124	0.00167	CcSEcCtD
Triamterene—Headache—Propofol—epilepsy syndrome	0.000123	0.00166	CcSEcCtD
Triamterene—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000123	0.00165	CcSEcCtD
Triamterene—Vomiting—Midazolam—epilepsy syndrome	0.000122	0.00165	CcSEcCtD
Triamterene—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000122	0.00165	CcSEcCtD
Triamterene—Asthenia—Felbamate—epilepsy syndrome	0.000122	0.00165	CcSEcCtD
Triamterene—Rash—Midazolam—epilepsy syndrome	0.000121	0.00163	CcSEcCtD
Triamterene—Dizziness—Fosphenytoin—epilepsy syndrome	0.000121	0.00163	CcSEcCtD
Triamterene—Dermatitis—Midazolam—epilepsy syndrome	0.000121	0.00163	CcSEcCtD
Triamterene—Vomiting—Levetiracetam—epilepsy syndrome	0.000121	0.00163	CcSEcCtD
Triamterene—Headache—Midazolam—epilepsy syndrome	0.00012	0.00162	CcSEcCtD
Triamterene—Diarrhoea—Diazepam—epilepsy syndrome	0.00012	0.00162	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.00012	0.00194	CbGpPWpGaD
Triamterene—Rash—Levetiracetam—epilepsy syndrome	0.00012	0.00161	CcSEcCtD
Triamterene—Dermatitis—Levetiracetam—epilepsy syndrome	0.000119	0.00161	CcSEcCtD
Triamterene—Asthenia—Zonisamide—epilepsy syndrome	0.000119	0.00161	CcSEcCtD
Triamterene—Dry mouth—Valproic Acid—epilepsy syndrome	0.000119	0.00161	CcSEcCtD
Triamterene—Headache—Levetiracetam—epilepsy syndrome	0.000119	0.0016	CcSEcCtD
Triamterene—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000118	0.00159	CcSEcCtD
Triamterene—Dizziness—Vigabatrin—epilepsy syndrome	0.000118	0.00159	CcSEcCtD
Triamterene—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000117	0.00158	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—MAP2—epilepsy syndrome	0.000117	0.0019	CbGpPWpGaD
Triamterene—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000117	0.00158	CcSEcCtD
Triamterene—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000117	0.00158	CcSEcCtD
Triamterene—Nausea—Propofol—epilepsy syndrome	0.000117	0.00157	CcSEcCtD
Triamterene—Vomiting—Fosphenytoin—epilepsy syndrome	0.000116	0.00157	CcSEcCtD
Triamterene—Diarrhoea—Felbamate—epilepsy syndrome	0.000116	0.00157	CcSEcCtD
Triamterene—Dizziness—Diazepam—epilepsy syndrome	0.000116	0.00157	CcSEcCtD
Triamterene—Rash—Fosphenytoin—epilepsy syndrome	0.000115	0.00156	CcSEcCtD
Triamterene—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000115	0.00156	CcSEcCtD
Triamterene—Asthenia—Clonazepam—epilepsy syndrome	0.000115	0.00155	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000115	0.00186	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000115	0.00186	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000115	0.00186	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000115	0.00186	CbGpPWpGaD
Triamterene—Headache—Fosphenytoin—epilepsy syndrome	0.000115	0.00155	CcSEcCtD
Triamterene—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000114	0.00154	CcSEcCtD
Triamterene—Asthenia—Phenytoin—epilepsy syndrome	0.000114	0.00154	CcSEcCtD
Triamterene—Nausea—Midazolam—epilepsy syndrome	0.000114	0.00154	CcSEcCtD
Triamterene—Diarrhoea—Zonisamide—epilepsy syndrome	0.000114	0.00154	CcSEcCtD
Triamterene—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000114	0.00153	CcSEcCtD
Triamterene—Vomiting—Vigabatrin—epilepsy syndrome	0.000113	0.00153	CcSEcCtD
Triamterene—Nausea—Levetiracetam—epilepsy syndrome	0.000113	0.00152	CcSEcCtD
Triamterene—Rash—Vigabatrin—epilepsy syndrome	0.000112	0.00152	CcSEcCtD
Triamterene—Dizziness—Felbamate—epilepsy syndrome	0.000112	0.00152	CcSEcCtD
Triamterene—Dermatitis—Vigabatrin—epilepsy syndrome	0.000112	0.00152	CcSEcCtD
Triamterene—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000112	0.00151	CcSEcCtD
Triamterene—Headache—Vigabatrin—epilepsy syndrome	0.000112	0.00151	CcSEcCtD
Triamterene—Vomiting—Diazepam—epilepsy syndrome	0.000112	0.00151	CcSEcCtD
Triamterene—Rash—Diazepam—epilepsy syndrome	0.000111	0.00149	CcSEcCtD
Triamterene—Dermatitis—Diazepam—epilepsy syndrome	0.000111	0.00149	CcSEcCtD
Triamterene—Dizziness—Zonisamide—epilepsy syndrome	0.00011	0.00148	CcSEcCtD
Triamterene—Headache—Diazepam—epilepsy syndrome	0.00011	0.00148	CcSEcCtD
Triamterene—Diarrhoea—Clonazepam—epilepsy syndrome	0.00011	0.00148	CcSEcCtD
Triamterene—Asthenia—Carbamazepine—epilepsy syndrome	0.000109	0.00147	CcSEcCtD
Triamterene—Diarrhoea—Phenytoin—epilepsy syndrome	0.000109	0.00147	CcSEcCtD
Triamterene—Nausea—Fosphenytoin—epilepsy syndrome	0.000109	0.00147	CcSEcCtD
Triamterene—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000108	0.00146	CcSEcCtD
Triamterene—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000108	0.00146	CcSEcCtD
Triamterene—Vomiting—Felbamate—epilepsy syndrome	0.000108	0.00146	CcSEcCtD
Triamterene—Dry mouth—Pregabalin—epilepsy syndrome	0.000108	0.00145	CcSEcCtD
Triamterene—Rash—Felbamate—epilepsy syndrome	0.000107	0.00145	CcSEcCtD
Triamterene—Dermatitis—Felbamate—epilepsy syndrome	0.000107	0.00144	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000107	0.00173	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000107	0.00173	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000107	0.00173	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000107	0.00173	CbGpPWpGaD
Triamterene—Headache—Felbamate—epilepsy syndrome	0.000106	0.00144	CcSEcCtD
Triamterene—Dizziness—Clonazepam—epilepsy syndrome	0.000106	0.00143	CcSEcCtD
Triamterene—Nausea—Vigabatrin—epilepsy syndrome	0.000106	0.00143	CcSEcCtD
Triamterene—Vomiting—Zonisamide—epilepsy syndrome	0.000106	0.00143	CcSEcCtD
Triamterene—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000106	0.00142	CcSEcCtD
Triamterene—Asthenia—Lamotrigine—epilepsy syndrome	0.000105	0.00142	CcSEcCtD
Triamterene—Dizziness—Phenytoin—epilepsy syndrome	0.000105	0.00142	CcSEcCtD
Triamterene—Rash—Zonisamide—epilepsy syndrome	0.000105	0.00142	CcSEcCtD
Triamterene—Dermatitis—Zonisamide—epilepsy syndrome	0.000105	0.00141	CcSEcCtD
Triamterene—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000105	0.00141	CcSEcCtD
Triamterene—Nausea—Diazepam—epilepsy syndrome	0.000104	0.00141	CcSEcCtD
Triamterene—Headache—Zonisamide—epilepsy syndrome	0.000104	0.00141	CcSEcCtD
Triamterene—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000104	0.0014	CcSEcCtD
Triamterene—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000103	0.00139	CcSEcCtD
Triamterene—Vomiting—Clonazepam—epilepsy syndrome	0.000102	0.00138	CcSEcCtD
Triamterene—Vomiting—Phenytoin—epilepsy syndrome	0.000101	0.00137	CcSEcCtD
Triamterene—Rash—Clonazepam—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Dermatitis—Clonazepam—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Nausea—Felbamate—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Fatigue—Valproic Acid—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Dizziness—Carbamazepine—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000101	0.00136	CcSEcCtD
Triamterene—Headache—Clonazepam—epilepsy syndrome	0.0001	0.00136	CcSEcCtD
Triamterene—Rash—Phenytoin—epilepsy syndrome	0.0001	0.00136	CcSEcCtD
Triamterene—Dermatitis—Phenytoin—epilepsy syndrome	0.0001	0.00135	CcSEcCtD
Triamterene—Rash—Oxcarbazepine—epilepsy syndrome	9.99e-05	0.00135	CcSEcCtD
Triamterene—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.98e-05	0.00135	CcSEcCtD
Triamterene—Headache—Phenytoin—epilepsy syndrome	9.98e-05	0.00135	CcSEcCtD
Triamterene—Headache—Oxcarbazepine—epilepsy syndrome	9.93e-05	0.00134	CcSEcCtD
Triamterene—Nausea—Zonisamide—epilepsy syndrome	9.88e-05	0.00133	CcSEcCtD
Triamterene—Dry mouth—Gabapentin—epilepsy syndrome	9.88e-05	0.00133	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.75e-05	0.00158	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.75e-05	0.00158	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.75e-05	0.00158	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.75e-05	0.00158	CbGpPWpGaD
Triamterene—Dizziness—Lamotrigine—epilepsy syndrome	9.72e-05	0.00131	CcSEcCtD
Triamterene—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	9.71e-05	0.00158	CbGpPWpGaD
Triamterene—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.68e-05	0.00131	CcSEcCtD
Triamterene—Vomiting—Carbamazepine—epilepsy syndrome	9.67e-05	0.0013	CcSEcCtD
Triamterene—Rash—Carbamazepine—epilepsy syndrome	9.59e-05	0.00129	CcSEcCtD
Triamterene—Dermatitis—Carbamazepine—epilepsy syndrome	9.58e-05	0.00129	CcSEcCtD
Triamterene—Nausea—Clonazepam—epilepsy syndrome	9.52e-05	0.00129	CcSEcCtD
Triamterene—Headache—Carbamazepine—epilepsy syndrome	9.52e-05	0.00129	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.5e-05	0.00154	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.5e-05	0.00154	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.5e-05	0.00154	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.5e-05	0.00154	CbGpPWpGaD
Triamterene—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.48e-05	0.00128	CcSEcCtD
Triamterene—Nausea—Phenytoin—epilepsy syndrome	9.46e-05	0.00128	CcSEcCtD
Triamterene—Nausea—Oxcarbazepine—epilepsy syndrome	9.41e-05	0.00127	CcSEcCtD
Triamterene—Vomiting—Lamotrigine—epilepsy syndrome	9.34e-05	0.00126	CcSEcCtD
Triamterene—Rash—Lamotrigine—epilepsy syndrome	9.26e-05	0.00125	CcSEcCtD
Triamterene—Dermatitis—Lamotrigine—epilepsy syndrome	9.26e-05	0.00125	CcSEcCtD
Triamterene—Headache—Lamotrigine—epilepsy syndrome	9.21e-05	0.00124	CcSEcCtD
Triamterene—Fatigue—Pregabalin—epilepsy syndrome	9.1e-05	0.00123	CcSEcCtD
Triamterene—CYP1A2—Xenobiotics—CYP2C19—epilepsy syndrome	9.06e-05	0.00147	CbGpPWpGaD
Triamterene—Nausea—Carbamazepine—epilepsy syndrome	9.03e-05	0.00122	CcSEcCtD
Triamterene—Nausea—Lamotrigine—epilepsy syndrome	8.73e-05	0.00118	CcSEcCtD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	8.71e-05	0.00142	CbGpPWpGaD
Triamterene—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.6e-05	0.00116	CcSEcCtD
Triamterene—Lamotrigine—ABCB1—epilepsy syndrome	8.45e-05	0.0204	CrCbGaD
Triamterene—Asthenia—Valproic Acid—epilepsy syndrome	8.38e-05	0.00113	CcSEcCtD
Triamterene—Fatigue—Gabapentin—epilepsy syndrome	8.35e-05	0.00113	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RET—epilepsy syndrome	8.31e-05	0.00135	CbGpPWpGaD
Triamterene—Dry mouth—Topiramate—epilepsy syndrome	8.31e-05	0.00112	CcSEcCtD
Triamterene—CYP1A2—Xenobiotics—CYP2D6—epilepsy syndrome	8.12e-05	0.00132	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.08e-05	0.00131	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.08e-05	0.00131	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.08e-05	0.00131	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.08e-05	0.00131	CbGpPWpGaD
Triamterene—Diarrhoea—Valproic Acid—epilepsy syndrome	7.99e-05	0.00108	CcSEcCtD
Triamterene—Thrombocytopenia—Topiramate—epilepsy syndrome	7.97e-05	0.00108	CcSEcCtD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	7.81e-05	0.00127	CbGpPWpGaD
Triamterene—Hypersensitivity—Pregabalin—epilepsy syndrome	7.78e-05	0.00105	CcSEcCtD
Triamterene—Dizziness—Valproic Acid—epilepsy syndrome	7.72e-05	0.00104	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.71e-05	0.00125	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.71e-05	0.00125	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.71e-05	0.00125	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.71e-05	0.00125	CbGpPWpGaD
Triamterene—Asthenia—Pregabalin—epilepsy syndrome	7.57e-05	0.00102	CcSEcCtD
Triamterene—Vomiting—Valproic Acid—epilepsy syndrome	7.42e-05	0.001	CcSEcCtD
Triamterene—Rash—Valproic Acid—epilepsy syndrome	7.36e-05	0.000993	CcSEcCtD
Triamterene—Dermatitis—Valproic Acid—epilepsy syndrome	7.36e-05	0.000992	CcSEcCtD
Triamterene—Headache—Valproic Acid—epilepsy syndrome	7.31e-05	0.000987	CcSEcCtD
Triamterene—Diarrhoea—Pregabalin—epilepsy syndrome	7.22e-05	0.000975	CcSEcCtD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	7.15e-05	0.00116	CbGpPWpGaD
Triamterene—Hypersensitivity—Gabapentin—epilepsy syndrome	7.13e-05	0.000962	CcSEcCtD
Triamterene—Fatigue—Topiramate—epilepsy syndrome	7.02e-05	0.000947	CcSEcCtD
Triamterene—Dizziness—Pregabalin—epilepsy syndrome	6.98e-05	0.000942	CcSEcCtD
Triamterene—Asthenia—Gabapentin—epilepsy syndrome	6.94e-05	0.000937	CcSEcCtD
Triamterene—Nausea—Valproic Acid—epilepsy syndrome	6.94e-05	0.000936	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	6.73e-05	0.00109	CbGpPWpGaD
Triamterene—Vomiting—Pregabalin—epilepsy syndrome	6.71e-05	0.000906	CcSEcCtD
Triamterene—Rash—Pregabalin—epilepsy syndrome	6.66e-05	0.000898	CcSEcCtD
Triamterene—Dermatitis—Pregabalin—epilepsy syndrome	6.65e-05	0.000897	CcSEcCtD
Triamterene—Diarrhoea—Gabapentin—epilepsy syndrome	6.62e-05	0.000894	CcSEcCtD
Triamterene—Headache—Pregabalin—epilepsy syndrome	6.61e-05	0.000892	CcSEcCtD
Triamterene—CYP1A2—Tryptophan metabolism—UBE3A—epilepsy syndrome	6.57e-05	0.00107	CbGpPWpGaD
Triamterene—Dizziness—Gabapentin—epilepsy syndrome	6.4e-05	0.000864	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.34e-05	0.00103	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.34e-05	0.00103	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.34e-05	0.00103	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.34e-05	0.00103	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.28e-05	0.00102	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.28e-05	0.00102	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.28e-05	0.00102	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.28e-05	0.00102	CbGpPWpGaD
Triamterene—Nausea—Pregabalin—epilepsy syndrome	6.27e-05	0.000846	CcSEcCtD
Triamterene—Vomiting—Gabapentin—epilepsy syndrome	6.15e-05	0.00083	CcSEcCtD
Triamterene—Rash—Gabapentin—epilepsy syndrome	6.1e-05	0.000824	CcSEcCtD
Triamterene—Dermatitis—Gabapentin—epilepsy syndrome	6.1e-05	0.000823	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.09e-05	0.000989	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.09e-05	0.000989	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.09e-05	0.000989	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.09e-05	0.000989	CbGpPWpGaD
Triamterene—Headache—Gabapentin—epilepsy syndrome	6.06e-05	0.000818	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	6.04e-05	0.00098	CbGpPWpGaD
Triamterene—Hypersensitivity—Topiramate—epilepsy syndrome	6e-05	0.00081	CcSEcCtD
Triamterene—Asthenia—Topiramate—epilepsy syndrome	5.84e-05	0.000788	CcSEcCtD
Triamterene—Nausea—Gabapentin—epilepsy syndrome	5.75e-05	0.000776	CcSEcCtD
Triamterene—Diarrhoea—Topiramate—epilepsy syndrome	5.57e-05	0.000752	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	5.51e-05	0.000894	CbGpPWpGaD
Triamterene—Dizziness—Topiramate—epilepsy syndrome	5.39e-05	0.000727	CcSEcCtD
Triamterene—Vomiting—Topiramate—epilepsy syndrome	5.18e-05	0.000699	CcSEcCtD
Triamterene—Rash—Topiramate—epilepsy syndrome	5.13e-05	0.000693	CcSEcCtD
Triamterene—Dermatitis—Topiramate—epilepsy syndrome	5.13e-05	0.000692	CcSEcCtD
Triamterene—Headache—Topiramate—epilepsy syndrome	5.1e-05	0.000688	CcSEcCtD
Triamterene—CYP1A2—Metapathway biotransformation—KCNAB2—epilepsy syndrome	4.84e-05	0.000787	CbGpPWpGaD
Triamterene—Nausea—Topiramate—epilepsy syndrome	4.84e-05	0.000653	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	4.35e-05	0.000707	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—JUN—epilepsy syndrome	4.04e-05	0.000656	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.81e-05	0.000618	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.81e-05	0.000618	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.81e-05	0.000618	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.81e-05	0.000618	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.79e-05	0.000616	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.79e-05	0.000615	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.76e-05	0.000611	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	3.75e-05	0.000609	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.74e-05	0.000607	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.71e-05	0.000603	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.69e-05	0.000599	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—APOE—epilepsy syndrome	3.44e-05	0.000559	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.37e-05	0.000548	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.33e-05	0.000541	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	3.06e-05	0.000498	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.05e-05	0.000495	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.03e-05	0.000492	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	2.91e-05	0.000473	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.74e-05	0.000444	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	2.59e-05	0.000421	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	1.89e-05	0.000306	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	1.89e-05	0.000306	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	1.68e-05	0.000273	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.65e-05	0.000269	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	1.63e-05	0.000265	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	1.62e-05	0.000263	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	1.61e-05	0.000262	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.6e-05	0.00026	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.59e-05	0.000258	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	1.53e-05	0.000248	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	1.52e-05	0.000246	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	1.47e-05	0.000239	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	1.45e-05	0.000236	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.43e-05	0.000233	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	1.43e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.34e-05	0.000218	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	1.32e-05	0.000214	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	1.32e-05	0.000214	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	1.31e-05	0.000212	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	1.28e-05	0.000209	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.26e-05	0.000204	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.14e-05	0.000186	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.11e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.1e-05	0.000179	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.1e-05	0.000179	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	8.92e-06	0.000145	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PDXK—epilepsy syndrome	8.4e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	8.4e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADK—epilepsy syndrome	8.4e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CERS1—epilepsy syndrome	8.4e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FAR1—epilepsy syndrome	8.4e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	8.4e-06	0.000136	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	7.68e-06	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PNPO—epilepsy syndrome	7.68e-06	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GAMT—epilepsy syndrome	7.68e-06	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	7.68e-06	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—QDPR—epilepsy syndrome	7.14e-06	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CA4—epilepsy syndrome	7.14e-06	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	7.12e-06	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COX3—epilepsy syndrome	6.71e-06	0.000109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PFKL—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	6.36e-06	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.22e-06	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.18e-06	0.0001	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NEU1—epilepsy syndrome	5.82e-06	9.46e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UPB1—epilepsy syndrome	5.82e-06	9.46e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ATIC—epilepsy syndrome	5.82e-06	9.46e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	5.6e-06	9.1e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GBE1—epilepsy syndrome	5.41e-06	8.79e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	5.41e-06	8.79e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.29e-06	8.59e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	5.09e-06	8.26e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	4.95e-06	8.04e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NT5E—epilepsy syndrome	4.82e-06	7.83e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALAD—epilepsy syndrome	4.82e-06	7.83e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.6e-06	7.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	4.6e-06	7.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.5e-06	7.31e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.41e-06	7.17e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.33e-06	7.03e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	4.25e-06	6.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.97e-06	6.45e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.86e-06	6.26e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.7e-06	6.02e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.49e-06	5.66e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.49e-06	5.66e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.25e-06	5.27e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.18e-06	5.17e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.84e-06	4.62e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.77e-06	4.5e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.75e-06	4.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.73e-06	4.44e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.49e-06	4.05e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.48e-06	4.04e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.37e-06	3.84e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.36e-06	3.83e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.25e-06	3.65e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.22e-06	3.61e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TH—epilepsy syndrome	2.21e-06	3.6e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.18e-06	3.54e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.85e-06	3e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.82e-06	2.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.77e-06	2.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.65e-06	2.68e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.45e-06	2.35e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.42e-06	2.3e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.22e-06	1.98e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.11e-06	1.8e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	9.71e-07	1.58e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.88e-07	7.93e-06	CbGpPWpGaD
